Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor ActivationBrent A. McLean, Daniel J. Drucker, David J. Hodson et al.|Endocrine Reviews|2020Cited by 268
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammationChi Kin Wong, Daniel J. Drucker, Theodore J. Brown et al.|Cell Metabolism|2023Cited by 251
Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammationChi Kin Wong, Daniel J. Drucker, Randy J. Seeley et al.|Cell Metabolism|2022Cited by 121
Molecular Characterization of the 2011 Hong Kong Scarlet Fever OutbreakHerman Tse, Kwok‐Yung Yuen, Mark J. Walker et al.|The Journal of Infectious Diseases|2012Cited by 112
Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutideBrent A. McLean, Daniel J. Drucker, Chi Kin Wong et al.|JCI Insight|2021Cited by 74